Skip to main content

Advertisement

SpringerLink
Log in

Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft

  • Spotlight Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Brito-Babapulle F . The eosinophilias, including the idiopathic hypereosinophilic Syndrome. Br J Haematol 2003; 121: 203–223.

    Article  Google Scholar 

  2. Vardiman JW, Harris NL, Brunning RD, The World Health Organization (WHO). Classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.

    Article  CAS  Google Scholar 

  3. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of Imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201–1214.

    Article  CAS  Google Scholar 

  4. Ueno NT, Anagnostopoulos A, Rondon G, Champlin RE, Mikhailova N, Pankratova OS et al. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 2002; 119: 131–134.

    Article  Google Scholar 

  5. Chockalingam A, Jalil A, Shadduck RK, Lister J . Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction. Bone Marrow Transplant 1999; 23: 1093–1094.

    Article  CAS  Google Scholar 

  6. Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase qchain reaction (RQ-PCR) of fusion gene transcripts for residual disease detection in leukemia – a Europe Against Cancer Program. Leukemia 2003; 17: 2318–2357.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'Onco-Hématologie, Hôpital St Vincent, Groupe Hospitalier de l'Institut Catholique, Lille, 59000, France

    C Rose, S Dupire, E Bourgeois & N Cambier

  2. Service d'Hématologie A Hôpital Calmette and Inserm U524 CHRU, Lille, 59000, France

    C Roche-Lestienne, N Grardel & C Preudhomme

Authors
  1. C Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Dupire
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Roche-Lestienne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Grardel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Bourgeois
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Cambier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C Preudhomme
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Preudhomme.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rose, C., Dupire, S., Roche-Lestienne, C. et al. Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft. Leukemia 18, 354–355 (2004). https://doi.org/10.1038/sj.leu.2403229

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403229

  • Springer Nature Limited

This article is cited by

Search

Navigation